クロファジミン

クロファジミン 化学構造式
2030-63-9
CAS番号.
2030-63-9
化学名:
クロファジミン
别名:
クロファジミン;3,5-ジヒドロ-N,5-ビス(4-クロロフェニル)-3-(イソプロピルイミノ)フェナジン-2-アミン;N,5-ビス(4-クロロフェニル)-3,5-ジヒドロ-3-(イソプロピルイミノ)-2-フェナジンアミン;ランプレン;N,5-ビス(4-クロロフェニル)-3,5-ジヒドロ-3-[(1-メチルエチル)イミノ]フェナジン-2-アミン;3-(p-クロロアニリノ)-10-(p-クロロフェニル)-2,10-ジヒドロ-2-(イソプロピルイミノ)フェナジン;N,5-ビス(4-クロロフェニル)-3,5-ジヒドロ-3-(イソプロピルイミノ)フェナジン-2-アミン;クロファジミン (JAN);N,5-ビス(4-クロロフェニル)-3-[(プロパン-2-イル)イミノ]-3,5-ジヒドロフェナジン-2-アミン
英語名:
Clofazimine
英語别名:
Lamprene;3-(p-chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenaz;4-chloro-N-(5-(4-chlorophenyl)-3,5-dihydro-3-isopropyliminophenazin-2-yl)aniline;b-663;g30320;lampren;nsc-141046;CLOFAZIMINE;Clofazimina;chlofazimine
CBNumber:
CB6273466
化学式:
C27H22Cl2N4
分子量:
473.4
MOL File:
2030-63-9.mol
MSDS File:
SDS

クロファジミン 物理性質

融点 :
210-212°
沸点 :
616.26°C (rough estimate)
比重(密度) :
1.1342 (rough estimate)
屈折率 :
1.6300 (estimate)
貯蔵温度 :
2-8°C
溶解性:
水にほとんど溶けず、ジクロロメタンに溶け、エタノールにわずかに溶ける (96%)。
酸解離定数(Pka):
8.37; also reported as 8.51(at 25℃)
色:
Yellow to Amber to Dark red
水溶解度 :
10mg/L(温度表記なし)
Merck :
14,2373
BCS Class:
4/3
安全性情報
  • リスクと安全性に関する声明
  • 危険有害性情報のコード(GHS)
主な危険性  Xn,Xi
Rフレーズ  22-36/37/38
Sフレーズ  36-26
WGK Germany  3
RTECS 番号 SG1578000
HSコード  35040000
毒性 LD50 orally in mice, rats, and guinea pigs: >4 g/kg (Stenger)
絵表示(GHS) GHS hazard pictograms
注意喚起語
危険有害性情報
コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード
H315 皮膚刺激 皮膚腐食性/刺激性 2 警告 GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 強い眼刺激 眼に対する重篤な損傷性/眼刺激 性 2A 警告 GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
H335 呼吸器への刺激のおそれ 特定標的臓器毒性、単回暴露; 気道刺激性 3 警告 GHS hazard pictograms
H413 長期的影響により水生生物に有害のおそれ 水生環境有害性、慢性毒性 4
注意書き
P264 取扱い後は皮膚をよく洗うこと。
P264 取扱い後は手や顔をよく洗うこと。
P280 保護手袋/保護衣/保護眼鏡/保護面を着用するこ と。
P302+P352 皮膚に付着した場合:多量の水と石鹸で洗うこと。
P305+P351+P338 眼に入った場合:水で数分間注意深く洗うこと。次にコ ンタクトレンズを着用していて容易に外せる場合は外す こと。その後も洗浄を続けること。
P321 特別な処置が必要である(このラベルの... を見よ)。
P332+P313 皮膚刺激が生じた場合:医師の診断/手当てを受けるこ と。
P362 汚染された衣類を脱ぎ、再使用す場合には洗濯をすること。

クロファジミン 価格 もっと(17)

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入
富士フイルム和光純薬株式会社(wako) W01USP1138904 クロファジミン
Clofazimine
2030-63-9 200mg ¥94200 2024-03-01 購入
東京化成工業 C2866 クロファジミン >98.0%(HPLC)(T)
Clofazimine >98.0%(HPLC)(T)
2030-63-9 1g ¥5700 2024-03-01 購入
東京化成工業 C2866 クロファジミン >98.0%(HPLC)(T)
Clofazimine >98.0%(HPLC)(T)
2030-63-9 5g ¥19700 2024-03-01 購入
Sigma-Aldrich Japan C8895 クロファジミン
Clofazimine
2030-63-9 1g ¥13100 2024-03-01 購入
Sigma-Aldrich Japan Y0000313 クロファジミン European Pharmacopoeia (EP) Reference Standard
Clofazimine European Pharmacopoeia (EP) Reference Standard
2030-63-9 y0000313 ¥19400 2024-03-01 購入

クロファジミン 化学特性,用途語,生産方法

外観

黄色~くすんだ黄色~暗い赤色粉末~結晶

効能

ハンセン病治療薬

商品名

ランプレン (サンド)

化学的特性

Red Solid

使用

antiinflammatory, glucocorticoid

定義

ChEBI: 3-Isopropylimino-3,5-dihydro-phenazine in which the hydrogen at position 5 is substituted substituted by a 4-chlorophenyl group, and that at position 2 is substituted by a (4-chlorophenyl)amino group. A dark red crystalline solid, clofazimine is an antimyc bacterial and is one of the main drugs used for the treatment of multi-bacillary leprosy. However, it can cause red/brown discolouration of the skin, so other treatments are often preferred in light-skinned patients.

適応症

Clofazimine is a weakly bactericidal dye that has some activity against M. leprae. Its precise mechanism of action is unknown but may involve mycobacterial DNA binding. Its oral absorption is quite variable, with 9 to 70% of the drug eliminated in the feces. Clofazimine achieves significant concentrations in tissues, including the phagocytic cells; it has a plasma half-life of 70 days. It is primarily excreted in bile, with less than 1% excretion in urine.

抗菌性

The mode of action is not fully understood. It has bacteristatic and weak bactericidal activity against several species of mycobacteria and some species of Actinomyces and Nocardia. In-vitro minimum inhibitory concentrations (MICs) are: M. tuberculosis 0.5 mg/L and M. leprae (assayed in a mouse model) 0.1–1 mg/L, but these MICs have limited clinical relevance as clofazimine shows marked differences in accumulation in various tissues. Activity against M. leprae is demonstrable in humans only after 50 days of therapy. Clofazimine resistance, although reported, appears to be rare.

応用例(製薬)

One of a number of substituted iminophenazine dyes originally synthesized as potential antituberculosis agents. It is almost insoluble in water. It stimulates various phagocyte functions including release of free oxygen radicals, but it is not clear whether this contributes to its antimicrobial activity. It also has anti-inflammatory properties, attributed to its ability to inhibit certain patterns of intracellular T-cell receptor- mediated signaling, making it a useful drug for treating leprosy reactions and possibly other autoimmune processes.

薬物動態学

Clofazimine is well absorbed by the intestine and is taken up by adipose tissue and cells of the macrophage/monocyte series, including those in the intestinal wall. It has a very long half-life (variously estimated as 10–70 days) and is eliminated, mostly unchanged, in the urine and feces.

薬理学

Clofazimine is a substituted iminophenazine that was first proposed for treating leprosy in 1962; however, it entered into medical practice toward the end of the 1980s. The mechanisms of its action is not definitively known, although there is the assumption that it can inhibit the formation of matrixes with DNA, which leads to a delay in the growth of mycobacteria. Clofazimine exhibits a bactericidal effect between that of dapsone and rifampicin. Synonym of this drug is lamprene.

臨床応用

Multibacillary leprosy (in combination with other anti-leprosy drugs)
Erythema nodosum leprosum (anti-inflammatory activity)
Clofazimine has been suggested as a drug for treatment of MDR tuberculosis, although its efficacy is unproven. It has been used to treat M. ulcerans infection (Buruli ulcer) but with limited responses. Use in disease caused by mycobacteria of the M. avium complex is no longer recommended as more effective and less toxic alternative agents are available.

副作用

Clofazimine is usually well tolerated, but some patients develop nausea, abdominal pain and diarrhea, relieved to some extent by taking the drug with a meal or glass of milk. Dose-related, reversible, skin discoloration is very common and is unacceptable to some patients. Discoloration of the hair, cornea, urine, sweat and tears also occurs. Infants born to mothers receiving clofazimine are reversibly pigmented at birth. Edema of the wall of the small intestine leading to subacute obstruction is a rare but serious complication of prolonged high-dose therapy for leprosy reactions. Deposition of clofazimine in lymph nodes may interfere with lymphatic drainage, occasionally manifesting as edema of the feet.

純化方法

Clofazimine recrystallises from acetone as dark red crystals. Its solubility in CHCl3 and EtOH is 7% and 0.1%, respectively,at room temperature. It is insoluble in H2O. It is antibacterial. [Barry et al. J Chem Soc 859 1958, Beilstein 25 III/IV 3033.]

クロファジミン 上流と下流の製品情報

原材料

準備製品


クロファジミン 生産企業

Global( 206)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21691 55
Hangzhou FandaChem Co.,Ltd.
008657128800458; +8615858145714
fandachem@gmail.com China 9348 55
career henan chemical co
+86-0371-86658258
sales@coreychem.com China 29914 58
Biochempartner
0086-13720134139
candy@biochempartner.com CHINA 967 58
Hubei Jusheng Technology Co.,Ltd.
18871490254
linda@hubeijusheng.com CHINA 28180 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873
sales@chemdad.com China 39916 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427
sales@conier.com China 49390 58
Shaanxi Dideu Medichem Co. Ltd
18192627656
1012@dideu.com China 3422 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Hefei TNJ Chemical Industry Co.,Ltd.
0551-65418671
sales@tnjchem.com China 34572 58

クロファジミン  スペクトルデータ(1HNMR)


2030-63-9(クロファジミン)キーワード:


  • 2030-63-9
  • 2-phenazinamine,3,5-dihydro-n,5-bis(4-chlorophenyl)-3-((1-methylethyl)imino)
  • b-663
  • b663(pharmaceutical)
  • N,10-Bis[4-chlorophenyl]-2,10-dihydro-2-[[1-methylethyl] imino]-3-phenazinamine
  • N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropyliaino)phenazin-2-amine
  • 3-(p-Chloroanilino)-10-(p-Chlorophenyl)-2,10-dihydro-2-(iso-propylimi-no)phenazine
  • nsc-141046
  • phenazine,2,10-dihydro-3-(p-chloroanilino)-10-(p-chlorophenyl)-2-(isopropylimi
  • RIMINOPHENAZINE
  • N,5-BIS(4-CHLOROPHENYL)-3,5-DIHYDRO-3-(ISOPROPYLIMINO)PHENAZIN-2-AMINE
  • CLOFAZIMINE
  • Clofazimine (200 mg)
  • 2-(4-Chloroanilino)-3-isopropyliMino-5-(4-chlorophenyl)-3,5-dihydrophenazine
  • N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-[(1-Methylethyl)iMino]-2-phenazinaMine
  • 2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-
  • chlofazimine
  • g30320
  • lampren
  • 3,5-dihydro-n,5-bis(4-chlorophenyl)-3-((1-methylethyl)imino)
  • (4-chlorophenyl)-[5-(4-chlorophenyl)-3-isopropylimino-phenazin-2-yl]amine
  • N,5-bis(4-chlorophenyl)-3-propan-2-ylimino-phenazin-2-amine
  • N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine
  • Clofazimine >
  • Clofazimine for system suitability CRS
  • Clofazimine CRS
  • Clofazimine USP/EP/BP
  • Clofazimine (1.0mg/ml in Acetonitrile) See KIT3553
  • N,5-Bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-3,5-dihydrophenazin-2-amine
  • Clofaziminum
  • ClofazimineQ: What is Clofazimine Q: What is the CAS Number of Clofazimine Q: What is the storage condition of Clofazimine
  • クロファジミン
  • 3,5-ジヒドロ-N,5-ビス(4-クロロフェニル)-3-(イソプロピルイミノ)フェナジン-2-アミン
  • N,5-ビス(4-クロロフェニル)-3,5-ジヒドロ-3-(イソプロピルイミノ)-2-フェナジンアミン
  • ランプレン
  • N,5-ビス(4-クロロフェニル)-3,5-ジヒドロ-3-[(1-メチルエチル)イミノ]フェナジン-2-アミン
  • 3-(p-クロロアニリノ)-10-(p-クロロフェニル)-2,10-ジヒドロ-2-(イソプロピルイミノ)フェナジン
  • N,5-ビス(4-クロロフェニル)-3,5-ジヒドロ-3-(イソプロピルイミノ)フェナジン-2-アミン
  • クロファジミン (JAN)
  • N,5-ビス(4-クロロフェニル)-3-[(プロパン-2-イル)イミノ]-3,5-ジヒドロフェナジン-2-アミン
  • 抗細菌薬
Copyright 2017 © ChemicalBook. All rights reserved